Can MMF Cause Convulsions?
Yes, mycophenolate mofetil (MMF) can cause seizures, though this is a rare but serious adverse effect, most commonly manifesting as posterior reversible encephalopathy syndrome (PRES).
Mechanism and Clinical Presentation
MMF-induced seizures typically occur through the development of PRES, a neurological syndrome characterized by:
- Seizures (often the presenting symptom)
- Altered mental status or confusion
- Headache
- Visual disturbances (including cortical blindness)
- Subcortical vasogenic edema on brain imaging (particularly in posterior hemispheres)
The FDA drug label does not explicitly list seizures as a common adverse effect in the standard adverse event tables 1. However, multiple case reports document MMF-associated PRES presenting with seizures 2, 3, 4, 5.
Risk Factors and Clinical Context
Highest risk scenarios include:
Renal impairment: Patients with acute kidney injury or chronic kidney disease accumulate extremely high serum mycophenolic acid concentrations, dramatically increasing toxicity risk 6. One case documented a serum level of 88 µg/mL (far above therapeutic range) in a patient with renal failure who developed seizures 6.
Systemic lupus erythematosus (SLE): Multiple reports describe PRES with seizures in SLE patients receiving MMF 2, 4, 5. The combination of underlying disease, hypertension, and immunosuppression creates particular vulnerability.
Hypertension: Approximately 75% of PRES cases occur with moderate-to-severe hypertension 7. MMF can contribute to endothelial damage and blood pressure dysregulation.
Clinical Recognition and Management
When seizures occur in a patient on MMF, immediately:
- Discontinue MMF - This is the most critical intervention 4, 5
- Obtain urgent brain MRI - Look for bilateral posterior hemispheric subcortical edema characteristic of PRES 4
- Control blood pressure aggressively - Target <140/90 mmHg using IV agents initially if needed 4
- Provide seizure prophylaxis - Levetiracetam is commonly used 4
- Check serum mycophenolic acid levels if available, especially in renal impairment 6
Prognosis and Reversibility
PRES is reversible when recognized promptly 2, 4, 5. In documented cases:
- Neurological symptoms resolved within days to weeks after MMF discontinuation 4
- Repeat imaging showed resolution of subcortical edema 4
- No permanent neurological sequelae occurred with timely intervention 4
However, delayed recognition risks cerebral hemorrhage and permanent damage 2.
Important Caveats
Do not attribute all neurological symptoms to the underlying disease. In SLE patients particularly, new seizures or altered mental status that cannot be explained by lupus activity should prompt immediate consideration of drug-induced PRES 2, 5. The guidelines on autoimmune hepatitis note that MMF can cause "progressive multifocal leukoencephalopathy" with prolonged use, another serious neurological complication 8.
Monitor renal function closely. The FDA label warns that patients with severe chronic renal impairment show higher plasma drug exposure, and doses >1g twice daily should be avoided in renal transplant patients with severe impairment 1. This is critical because renal dysfunction dramatically increases seizure risk through drug accumulation 6.
While MMF is generally well-tolerated and widely used across multiple guidelines for conditions like atopic dermatitis 9, immune thrombocytopenia 8, autoimmune hepatitis 10, and SLE 11, clinicians must maintain vigilance for this rare but serious neurological complication.